Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 4,722 shares at $37.76 ($179K) on 2024-01-11, disclosed to the SEC on 2024-01-16.
Scheduled sale ($179k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.76 | 1,811 | $68K | 38.2% |
| 2 | $37.76 | 1,811 | $68K | 38.2% |
| 3 | $38.55 | 1,100 | $42K | 23.7% |
| Total | $37.94 avg | 4,722 | $179K | 100% |
| Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |
| ARWR | SELL | 2021-09-10 | $326K | — | Filing → |